Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18951,915,1.03 [0.96-1.12],0.3974586316553625
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,18214,295,1.02 [0.89-1.16],0.7824176577952864
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21487,177,0.98 [0.83-1.16],0.8403670830438859
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13318,1082,1.05 [0.98-1.13],0.1814880857700073
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21441,131,0.94 [0.78-1.15],0.5730273260294719
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19012,97,1.19 [0.95-1.49],0.1343574560905672
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22900,130,0.95 [0.78-1.16],0.6356201098745022
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22887,87,0.96 [0.75-1.23],0.7505645626241522
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18511,71,1.14 [0.88-1.48],0.33393622276336
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21744,134,1.10 [0.91-1.34],0.3137426935129905
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21698,88,1.12 [0.89-1.42],0.3360661927499874
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23008,70,1.02 [0.78-1.34],0.867696194611006
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23040,66,1.03 [0.78-1.35],0.8413085091435757
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23037,63,1.08 [0.82-1.43],0.5733487008428808
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,22534,62,0.98 [0.74-1.31],0.9117597657803366
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21422,440,1.08 [0.97-1.21],0.1412113202371792
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21116,134,1.10 [0.91-1.34],0.3141104414658534
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21307,325,1.08 [0.95-1.22],0.2503880249120118
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",16551,101,0.90 [0.72-1.13],0.3747589720172055
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16513,63,0.94 [0.71-1.25],0.659865871414024
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16853,403,1.02 [0.91-1.14],0.7164385067766073
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16865,415,1.02 [0.91-1.14],0.7434944034194718
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",9465,380,0.98 [0.87-1.10],0.7169057876560373
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7572,207,0.96 [0.82-1.13],0.6173121197297607
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16509,59,0.94 [0.70-1.26],0.684690071144451
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19668,770,1.09 [1.01-1.19],0.031947440126604
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21513,465,0.97 [0.87-1.08],0.5418721089775007
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22508,153,0.91 [0.75-1.09],0.2960456322368296
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23095,150,0.91 [0.75-1.10],0.3192829245635846
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,22781,85,0.99 [0.78-1.26],0.9257624468603788
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23102,98,1.22 [0.98-1.52],0.0777375704631712
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Stomach,23158,72,1.13 [0.87-1.46],0.3726409525255041
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,22921,295,0.96 [0.84-1.09],0.5151258963328333
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23141,102,0.99 [0.80-1.24],0.9646921848605138
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23144,84,0.83 [0.64-1.06],0.139015977032623
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23058,59,1.08 [0.81-1.44],0.601340441783246
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",23061,58,1.11 [0.83-1.49],0.4781444027081672
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,22998,149,1.22 [1.02-1.46],0.029318367799245
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23137,64,1.23 [0.93-1.61],0.1431381523920972
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,23018,174,0.98 [0.83-1.17],0.8573245087693494
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of breast,12086,45,0.83 [0.59-1.16],0.2755734721856792
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Leiomyoma of uterus,11941,308,0.96 [0.85-1.10],0.5724224890989901
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21574,197,1.13 [0.97-1.33],0.1214013575170456
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21040,353,1.17 [1.04-1.32],0.0081450423470018
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21040,353,1.17 [1.04-1.32],0.0081450423470018
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18487,567,1.02 [0.92-1.12],0.7572275221108099
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22529,58,0.62 [0.46-0.85],0.0028562358567165
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22810,59,1.02 [0.76-1.37],0.8926771181256791
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16726,1662,0.99 [0.93-1.05],0.7727027184327018
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21418,647,1.04 [0.95-1.14],0.3713990290679407
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20350,157,1.10 [0.92-1.31],0.3023410981495751
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21536,174,1.05 [0.88-1.24],0.5849494556703683
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20335,142,1.04 [0.86-1.26],0.6596327442505159
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,20975,782,1.07 [0.99-1.17],0.1036450843593715
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,20948,755,1.06 [0.97-1.16],0.1819189105334717
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21268,187,0.90 [0.74-1.08],0.2637898699343455
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21267,186,0.90 [0.74-1.08],0.2626874231081094
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16543,1479,0.98 [0.92-1.04],0.4829993035464994
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15254,190,0.96 [0.81-1.13],0.6081742793230539
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16434,1370,0.98 [0.92-1.05],0.5579129431748063
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15122,58,1.32 [0.99-1.75],0.057832320199872
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15156,92,1.00 [0.79-1.27],0.9988657822750764
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,18965,542,1.04 [0.94-1.15],0.4424517724749754
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18584,161,1.10 [0.92-1.32],0.297103818107331
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22790,113,1.12 [0.91-1.38],0.2923454772055557
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22849,85,1.19 [0.94-1.52],0.1514217736296773
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21603,34,1.14 [0.78-1.66],0.4909600179249483
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23080,34,1.15 [0.79-1.67],0.4734202347648364
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",18457,34,1.14 [0.78-1.66],0.4955229708949177
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Alcohol dependence,21613,44,1.03 [0.73-1.46],0.8536595774755935
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,21534,51,1.17 [0.86-1.60],0.3243551792448854
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18459,36,0.95 [0.65-1.39],0.7961463149625762
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",18686,263,1.12 [0.97-1.28],0.1241424460122879
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression,21707,233,1.09 [0.94-1.26],0.2495941125613481
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,18324,200,1.11 [0.95-1.31],0.1830113063625807
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",18534,111,0.87 [0.70-1.08],0.2124721595661192
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,21757,64,0.88 [0.66-1.17],0.3805934495057197
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,18817,1496,1.05 [0.98-1.11],0.1425481359485401
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16461,101,1.10 [0.88-1.37],0.4216891016814809
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23067,77,1.02 [0.79-1.31],0.8992540613126637
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21825,472,1.01 [0.91-1.12],0.9046701599408588
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,21488,135,0.90 [0.74-1.10],0.3111934484193299
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,21412,59,0.95 [0.71-1.28],0.7302805735703186
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22924,53,0.96 [0.70-1.31],0.7963071532693125
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21973,117,1.06 [0.86-1.30],0.5948406477486119
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,21514,161,1.07 [0.90-1.28],0.4402634028800466
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,22629,122,1.06 [0.87-1.31],0.5518031525373025
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",21953,719,1.10 [1.01-1.19],0.0353473744213706
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21340,106,1.05 [0.85-1.31],0.656536912440919
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21673,439,1.10 [0.99-1.23],0.0805663121185906
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22771,80,0.96 [0.75-1.24],0.7500744378356037
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,22752,61,0.95 [0.71-1.27],0.7304001623522467
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,22598,118,0.88 [0.72-1.09],0.2551748596816574
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22293,421,0.98 [0.88-1.10],0.7318224947990355
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22127,255,1.04 [0.90-1.19],0.6186145612541041
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21933,61,0.75 [0.56-1.02],0.064458891207805
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22007,135,1.10 [0.91-1.33],0.3407450227457848
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21977,105,1.14 [0.92-1.41],0.2367497096258876
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17722,257,1.00 [0.87-1.16],0.9775771505601668
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18074,609,1.05 [0.95-1.15],0.3396225554516122
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,21754,311,1.17 [1.03-1.33],0.0145536392123231
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22737,82,1.30 [1.02-1.65],0.0355655311074286
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2611,82,1.25 [0.98-1.61],0.0764671996828705
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20208,82,1.31 [1.03-1.67],0.0292434899182826
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22175,144,0.90 [0.74-1.09],0.2719822038895888
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22109,78,1.07 [0.83-1.37],0.6186209936735851
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22231,80,0.94 [0.73-1.21],0.6112452269283124
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22470,98,0.81 [0.64-1.02],0.0747610509908905
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23065,144,1.03 [0.86-1.24],0.7501080677842159
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,21929,111,0.89 [0.72-1.11],0.2986626251444665
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,14265,4602,0.97 [0.93-1.01],0.1686513149203362
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22196,98,0.87 [0.69-1.09],0.2181187787721661
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",15117,3229,1.03 [0.98-1.08],0.2402210730472033
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,15161,3273,1.03 [0.98-1.08],0.2164965206432902
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12001,113,1.14 [0.92-1.42],0.2250349496434339
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20272,1835,0.95 [0.89-1.00],0.0524921279848882
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,19529,1092,0.93 [0.86-1.00],0.0410500682769739
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21769,347,1.06 [0.93-1.19],0.387425688965095
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22122,700,0.98 [0.90-1.07],0.7109955117770185
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22997,132,0.98 [0.81-1.19],0.8415496501753865
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18874,437,0.91 [0.81-1.01],0.0896177741659304
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19902,1489,0.96 [0.90-1.02],0.1745012796883661
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22005,137,1.05 [0.86-1.27],0.649401537136002
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22226,281,1.05 [0.92-1.21],0.4421738436117836
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21984,116,0.82 [0.66-1.02],0.0689398050316336
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21985,117,0.82 [0.66-1.02],0.0722609656965751
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12000,112,0.86 [0.69-1.06],0.1608766942604604
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16992,71,1.26 [0.97-1.63],0.0869400144567837
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,17096,175,0.80 [0.67-0.95],0.0121408396293908
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9005,140,0.77 [0.63-0.94],0.0089512606634306
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9556,691,0.81 [0.73-0.88],6.641329488603692e-06
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17015,94,0.92 [0.73-1.17],0.4955329220338046
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17044,123,0.65 [0.53-0.81],9.60815493297318e-05
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21512,297,0.98 [0.86-1.12],0.7557528213130278
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",21872,197,1.02 [0.87-1.20],0.781201489303929
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",21907,177,1.01 [0.85-1.19],0.9433537307429896
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22015,159,1.03 [0.86-1.23],0.7316369896475781
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21507,109,0.91 [0.73-1.13],0.4049359741585615
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21578,180,1.04 [0.88-1.23],0.6554125673832714
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21429,167,1.05 [0.88-1.25],0.5735579447400618
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21406,144,1.03 [0.85-1.25],0.7466481040600101
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22874,138,1.07 [0.88-1.29],0.514720245339997
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,21778,516,1.00 [0.91-1.11],0.9725572307730406
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,21468,120,0.95 [0.77-1.17],0.6350589815314147
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17067,2165,1.04 [0.99-1.10],0.1323168892768806
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22996,76,1.06 [0.82-1.38],0.6351699634720533
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20584,258,0.97 [0.85-1.12],0.7233954760892307
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20555,229,0.99 [0.86-1.15],0.9427205200129408
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,21880,290,1.02 [0.89-1.16],0.7895087327407828
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,21871,281,1.01 [0.89-1.16],0.8461139997737384
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22431,548,0.99 [0.90-1.09],0.8183672466273689
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,21973,90,0.88 [0.70-1.12],0.3172309508532147
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,22021,138,1.09 [0.90-1.32],0.3569229406746717
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22234,351,0.98 [0.87-1.11],0.7611645104150067
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22018,135,0.91 [0.75-1.10],0.3276217571551064
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7344,75,1.01 [0.78-1.32],0.9121802500753204
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20045,1139,1.12 [1.05-1.20],0.0007767995216882
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,21498,245,1.16 [1.00-1.33],0.0451722222494212
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21546,293,1.15 [1.01-1.32],0.0308372274297848
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21546,293,1.15 [1.01-1.32],0.0308372274297848
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21465,870,1.12 [1.04-1.21],0.0029698176559884
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Asthma,15045,870,1.14 [1.05-1.23],0.0012319851246321
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14655,870,1.14 [1.05-1.23],0.0012843577095201
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15035,860,1.13 [1.04-1.22],0.0026504408268893
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22583,127,0.87 [0.71-1.06],0.1734880239651396
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21516,99,0.95 [0.75-1.19],0.6357110051863726
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22682,99,0.95 [0.75-1.19],0.6273635114264096
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21509,92,0.89 [0.71-1.14],0.3597341509268921
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,20333,146,0.86 [0.71-1.04],0.1115782662038897
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,20486,299,0.94 [0.82-1.07],0.3338070734851713
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21458,133,0.98 [0.81-1.19],0.8371225524625314
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14971,6479,1.00 [0.96-1.04],0.9782174217063
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22710,336,1.00 [0.88-1.13],0.9851199752806408
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23155,41,1.20 [0.85-1.69],0.2931162519546167
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,23157,37,1.29 [0.90-1.84],0.1648975348723194
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,22465,91,1.01 [0.80-1.28],0.9351961241265327
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22466,92,1.04 [0.82-1.31],0.740345280124167
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23151,45,1.10 [0.79-1.54],0.5545172628604158
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22470,96,0.89 [0.70-1.12],0.3067776889889589
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22199,92,0.94 [0.75-1.19],0.6247739008183288
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23048,61,1.00 [0.75-1.33],0.9994080189641033
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16332,343,1.01 [0.90-1.15],0.823438681995322
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18580,2591,0.97 [0.93-1.02],0.2761472138578392
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,16400,411,1.07 [0.96-1.20],0.2030570186241862
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16830,841,0.97 [0.90-1.05],0.4852074426400772
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16076,87,1.01 [0.79-1.28],0.9569241954288342
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16272,283,0.98 [0.86-1.12],0.7972597208041855
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16074,85,1.07 [0.84-1.36],0.5815975566509003
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,16194,205,0.94 [0.80-1.10],0.4140673017686094
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,16133,144,1.18 [0.98-1.41],0.0836868673914667
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22978,98,1.16 [0.93-1.45],0.189706945306348
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,16139,150,0.90 [0.75-1.09],0.2921528419968306
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16980,991,0.93 [0.87-1.01],0.0674555553580717
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23029,89,1.08 [0.85-1.37],0.5274537576605904
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16476,487,0.95 [0.86-1.06],0.3428990749821717
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16213,224,0.93 [0.80-1.09],0.3695930105601747
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23024,122,0.86 [0.70-1.06],0.1552950160292268
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23016,76,1.13 [0.88-1.46],0.33128067336233
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,19514,2078,1.03 [0.98-1.09],0.2365836277667289
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,18227,791,0.97 [0.90-1.06],0.5213288903496456
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,17572,136,0.96 [0.78-1.17],0.6559736686765911
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,17546,110,1.11 [0.89-1.37],0.3464404546271914
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18573,1137,1.07 [1.00-1.15],0.0404695113754493
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22095,767,0.99 [0.91-1.08],0.8277585568055003
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,16955,2336,0.99 [0.94-1.04],0.5980087624058132
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22803,46,1.06 [0.77-1.48],0.7098103488995869
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23094,60,0.96 [0.72-1.28],0.7703241558313645
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,21388,60,0.96 [0.72-1.28],0.7770172026789937
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21373,45,0.82 [0.59-1.16],0.2659732699894357
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23013,142,1.00 [0.82-1.20],0.96188257577295
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21470,142,1.00 [0.83-1.21],0.9922594615640838
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21460,132,1.01 [0.83-1.23],0.9136580473135658
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21962,634,0.97 [0.89-1.06],0.5282525015474222
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21953,625,0.97 [0.88-1.06],0.4829038180896425
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14748,129,1.04 [0.85-1.27],0.7018813818284233
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal stricture,22561,129,1.05 [0.86-1.27],0.6476426822008
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14703,84,1.09 [0.85-1.39],0.4991939407486793
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15534,915,1.01 [0.93-1.09],0.840675544174462
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14774,155,0.97 [0.81-1.16],0.7217541378607509
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14944,325,1.02 [0.90-1.16],0.7745270462238759
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,21042,293,1.01 [0.88-1.15],0.8861035637952952
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22670,95,1.09 [0.87-1.37],0.4689191656664533
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14726,107,0.87 [0.70-1.10],0.2448786815288682
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14673,54,1.06 [0.78-1.45],0.6946167247778996
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15582,963,0.99 [0.91-1.06],0.729601580707244
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14983,364,0.98 [0.87-1.10],0.7106553142473009
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22654,79,1.09 [0.85-1.40],0.5146490110567964
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,22254,125,0.79 [0.64-0.98],0.0289881252039076
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,22200,71,0.82 [0.62-1.08],0.1567829107031643
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21648,735,1.06 [0.98-1.16],0.148014559347451
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,21513,600,1.08 [0.98-1.18],0.1032058542045574
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,21034,121,1.14 [0.93-1.39],0.2083450100814359
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20969,56,1.13 [0.84-1.52],0.4103626412524704
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,20988,75,1.18 [0.91-1.52],0.2051481987948479
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),22969,75,1.17 [0.91-1.51],0.227965007234608
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21654,346,1.07 [0.95-1.21],0.2478132099234319
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21383,75,1.30 [1.01-1.67],0.0393622863155795
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,21372,64,1.34 [1.02-1.75],0.0329030063766482
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21367,59,1.18 [0.88-1.56],0.2666540426911363
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21524,216,0.98 [0.84-1.14],0.7536153781920043
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,21515,207,0.96 [0.82-1.13],0.6541332586652093
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19436,1618,0.97 [0.92-1.03],0.3363034955599453
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22621,106,0.95 [0.76-1.19],0.6492270981856193
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22741,442,0.95 [0.85-1.06],0.3456826617651428
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,21062,621,1.01 [0.92-1.11],0.7891669489525364
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22103,390,0.97 [0.86-1.09],0.5756789612528681
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21783,70,0.96 [0.74-1.26],0.7838431433115193
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,21992,279,0.98 [0.85-1.12],0.7710714630752198
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22848,97,0.99 [0.78-1.24],0.9040389377888588
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22822,71,1.04 [0.79-1.36],0.7845058835306022
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22809,58,1.07 [0.80-1.44],0.6343586010383138
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22727,80,0.87 [0.67-1.12],0.2697148901970408
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22725,78,0.87 [0.67-1.12],0.2826553267212272
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22350,51,0.98 [0.72-1.35],0.9186121202118482
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22667,368,0.93 [0.83-1.05],0.262423926384815
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20556,115,0.97 [0.78-1.19],0.7453500895153661
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20542,101,0.78 [0.62-0.98],0.0354840751582192
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20510,69,0.84 [0.63-1.10],0.2038497365233869
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20665,224,1.06 [0.91-1.23],0.4602662495005981
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20646,205,1.04 [0.89-1.22],0.5896019428727001
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15125,4436,1.07 [1.02-1.11],0.0024665055763138
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16718,2761,1.08 [1.03-1.13],0.0014234746129922
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20534,1300,1.04 [0.98-1.11],0.1884623147182076
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14136,179,1.25 [1.06-1.48],0.0075915720748994
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14547,590,1.10 [1.00-1.21],0.0509604404658666
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22646,173,1.24 [1.05-1.46],0.0125842375276784
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22652,158,1.29 [1.09-1.53],0.0038661498438075
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15596,1639,1.10 [1.03-1.16],0.0023835858641268
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",18128,1639,1.09 [1.03-1.16],0.0030846843747753
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14054,97,1.04 [0.82-1.31],0.7660038503382001
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22379,94,1.00 [0.79-1.27],0.9865199367914326
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14252,295,1.07 [0.93-1.22],0.3459250510314344
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14077,120,0.91 [0.74-1.13],0.3987808145114825
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14395,438,1.18 [1.05-1.31],0.0034416714146248
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22937,217,1.28 [1.10-1.48],0.0011895843174874
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14684,727,1.08 [0.99-1.18],0.0989383566790895
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14526,569,1.04 [0.94-1.14],0.4684119009616204
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15286,1329,1.05 [0.99-1.12],0.1215961174587116
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14050,93,1.09 [0.87-1.38],0.4519696996201786
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14255,298,1.03 [0.90-1.18],0.6514352463619328
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14034,77,0.96 [0.74-1.25],0.775120383165296
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14048,91,1.11 [0.87-1.40],0.3979857921017761
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14392,435,1.07 [0.95-1.19],0.2556338976236408
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14349,392,1.06 [0.95-1.19],0.3021990189640355
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17390,275,1.01 [0.88-1.16],0.8712578769137018
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22419,104,1.09 [0.88-1.36],0.4393584484964098
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22386,71,1.57 [1.22-2.01],0.0004024216855069
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19143,75,1.02 [0.79-1.33],0.8637259577151783
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19440,372,0.92 [0.82-1.04],0.1751053789410773
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20016,948,0.98 [0.90-1.05],0.5270765980654019
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19311,243,0.88 [0.76-1.03],0.1036684031458656
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19181,113,1.06 [0.86-1.31],0.573788809706745
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19767,699,1.01 [0.92-1.10],0.8541613577306223
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19112,44,1.33 [0.96-1.84],0.0902504574467083
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19286,218,1.05 [0.90-1.23],0.4994312904115274
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19157,89,1.02 [0.80-1.30],0.8652918610619565
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19153,85,0.96 [0.75-1.22],0.7318534388484819
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19201,133,1.05 [0.86-1.27],0.6446693626073847
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19128,60,0.90 [0.67-1.21],0.4881250509228545
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19356,288,0.97 [0.85-1.12],0.71116657019397
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19568,334,1.10 [0.97-1.24],0.1422821224542822
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19316,82,1.04 [0.81-1.33],0.7653743417499336
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19353,119,0.93 [0.75-1.15],0.4951160824969011
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19320,86,1.31 [1.04-1.66],0.022313493282414
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19276,42,1.08 [0.76-1.52],0.6762522880487122
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19402,168,0.95 [0.80-1.13],0.5481376118322985
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19392,158,0.93 [0.78-1.11],0.4307277791926497
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19528,294,1.11 [0.97-1.26],0.1223829788247121
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19291,57,0.99 [0.74-1.34],0.971447222085554
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19333,99,0.96 [0.77-1.21],0.7374268142166214
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19373,139,1.17 [0.97-1.41],0.1058311276599599
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19284,50,0.78 [0.56-1.08],0.1408858452061191
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",19691,457,0.99 [0.89-1.11],0.9063691438871782
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19422,188,0.95 [0.81-1.13],0.575755379027461
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19488,254,0.95 [0.82-1.10],0.5026660370190592
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,20760,241,0.96 [0.83-1.11],0.5715292779059455
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,20954,435,0.99 [0.89-1.11],0.9164371149775644
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20558,39,0.92 [0.64-1.32],0.6521002917267811
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20568,49,1.10 [0.80-1.51],0.5561166285984519
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20608,89,1.05 [0.83-1.34],0.6590976680514766
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16881,4103,0.98 [0.94-1.02],0.4296058400155668
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8933,863,0.97 [0.89-1.05],0.4573192997717278
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19406,298,1.20 [1.06-1.37],0.005025333055357
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19191,83,1.12 [0.87-1.43],0.3788362611403456
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19457,67,1.43 [1.09-1.86],0.0087258957654771
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19481,91,1.26 [1.00-1.59],0.05026917937691
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19472,82,1.17 [0.91-1.50],0.2108625625774268
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22787,253,0.95 [0.82-1.10],0.4731792178332085
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22550,93,1.36 [1.08-1.69],0.0074611353752803
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22722,188,0.99 [0.84-1.16],0.8732620239518256
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22610,76,0.91 [0.70-1.19],0.4897277164927565
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,20221,1213,1.06 [0.99-1.13],0.1021793701574731
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,19122,114,1.06 [0.86-1.31],0.572962371888847
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19100,92,1.05 [0.83-1.33],0.671981503224423
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19380,372,0.98 [0.87-1.10],0.752480654043476
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19150,142,1.02 [0.84-1.23],0.8697258645555415
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19748,740,1.09 [1.01-1.19],0.0356228187777461
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8564,494,1.00 [0.90-1.11],0.9663005143195272
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8138,68,0.92 [0.69-1.21],0.5359292565313793
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8131,61,0.99 [0.74-1.32],0.9340338924954716
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8141,71,0.89 [0.67-1.17],0.3990551461890645
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8164,94,1.02 [0.81-1.29],0.8561161766020291
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8181,111,0.91 [0.73-1.13],0.3774359320612207
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11975,228,0.83 [0.71-0.97],0.0170763454734397
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11822,75,0.76 [0.58-1.00],0.0463147773383945
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,11826,79,0.81 [0.63-1.05],0.1175274286663691
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11807,60,0.93 [0.69-1.24],0.6225620658669824
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11949,166,1.00 [0.84-1.19],0.9826758961340326
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,11835,52,0.82 [0.60-1.13],0.2348591621743799
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11839,56,1.07 [0.80-1.44],0.6422338037244051
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11083,1822,0.97 [0.91-1.02],0.234351328102109
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9326,65,1.12 [0.85-1.47],0.4297948751471423
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9313,52,1.15 [0.84-1.56],0.3838205072754455
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9749,488,1.07 [0.96-1.19],0.2082579412552457
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9368,107,1.06 [0.85-1.32],0.5954023630722984
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9745,484,0.90 [0.81-1.00],0.047726744928736
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9412,151,0.72 [0.59-0.87],0.0005711021837823
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9481,220,0.98 [0.84-1.14],0.7889392201374523
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9278,17,0.99 [0.58-1.71],0.9781406436499036
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9308,47,0.84 [0.60-1.18],0.3086625641921293
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",12099,64,0.87 [0.66-1.16],0.3504627366532749
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,12101,59,0.88 [0.65-1.18],0.397570536535026
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,12107,30,0.97 [0.64-1.46],0.8862843254445942
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",12105,34,0.95 [0.65-1.40],0.8138299297748324
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9333,72,0.95 [0.73-1.24],0.7208868347950552
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9314,53,1.05 [0.77-1.43],0.74720125924893
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9329,68,1.41 [1.09-1.83],0.0101276902802349
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,12106,90,1.05 [0.83-1.33],0.6811514882476108
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9458,197,0.90 [0.76-1.06],0.2004807953663613
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9351,90,0.81 [0.63-1.03],0.0843483797120577
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",12108,41,1.01 [0.71-1.43],0.9458459891994664
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9372,111,0.90 [0.73-1.12],0.3437596612097993
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9310,49,1.12 [0.82-1.54],0.4762954099874611
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9893,632,0.90 [0.82-0.99],0.0295037813379336
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22608,85,0.87 [0.68-1.12],0.2744240757208664
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19723,666,1.02 [0.93-1.11],0.6976842613255781
